发明名称 Topiramate salts and compositions comprising and methods of making and using the same
摘要 The invention encompasses novel salts of topiramate, and pharmaceutically acceptable polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, or amorphous forms thereof, as well as pharmaceutical compositions and pharmaceutical unit dosage forms containing the same. In particular, the invention encompasses pharmaceutically acceptable salts of topiramate, including without limitation topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms thereof. The invention further encompasses novel co-crystals or complexes of topiramate, as well as pharmaceutical compositions comprising them. The invention also encompasses methods of treating or preventing a variety of diseases and conditions including, but not limited to, seizures, epileptic conditions, tremors, cerebral function disorders, obesity, neuropathic pain, affective disorders, tobacco cessation, migraines, and cluster headache.
申请公布号 US7351695(B2) 申请公布日期 2008.04.01
申请号 US20030716976 申请日期 2003.11.19
申请人 ORTHO-MCNEIL PHARMACEUTICALS, INC. 发明人 ALMARSSOO OEM;REMENAR JULES;PETERSON MATTHEW L.
分类号 A01N43/04;C07D473/12;A61K9/00;A61K9/16;A61K9/24;A61K31/19;A61K31/195;A61K31/4015;A61K31/4166;A61K31/522;A61K31/53;A61K31/55;A61K31/70;A61K31/7028;A61K47/10;A61K47/32;A61P1/08;A61P1/14;A61P3/04;A61P9/12;A61P11/02;A61P15/00;A61P25/00;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/34;A61P27/02;A61P43/00;C07H5/04;C07H5/06;C07H11/00;G01N33/15 主分类号 A01N43/04
代理机构 代理人
主权项
地址